Agenda and minutes

It was noted that Councillor Radia would be arriving a little late and that Councillor Nelson was on her way. 

RESOLVED:  That all items of business be considered in public.

The Chairman welcomed those present to the meeting.  He noted that Mr Nick Hunt had given his apologies for this meeting and that any queries in relation to the Royal Brompton and Harefield NHS Foundation Trust (RBH) Quality Account (QA) 2018/2019 report would need to be forwarded to him for response. 

Hillingdon Clinical Commissioning Group (HCCG)

Ms Caroline Morison, HCCG Managing Director, advised that the Trust did not produce a QA report as it was a commissioner.  However, Ms Morison was able to talk to Members about HCCG’s role in the QA process and how the organisation monitored the quality of the services that it commissioned. 

Ms Morison advised that HCCG worked through NHS England (NHSE) and NHS Improvement (NHSI).  It was noted that these two London offices were currently being brought together as one. 

Ms Jennifer Roye, Deputy Director of Quality, advised that HCCG was part of the North West London (NWL) Collaboration of eight CCGs.  A single Quality Director was responsible for the quality agenda across the eight CCGs and was supported by three deputies (one of which was Ms Roye and another of which had a focus on safeguarding).  Each of the eight CCGs also had an Assistant Director of Quality who led on the quality agenda locally.  

Members were advised that the quality of a service was measured by looking at patient safety, the effectiveness of the treatment patients received and the feedback about care provided.  Providers were required to submit their final QA report to the Department of Health by 30 June 2019.  HCCG was able to provide comments for inclusion in the final QA report and routinely requested that it be involved in the associated stakeholder events.  This year, HCCG had not been invited to participate in The Hillingdon Hospitals NHS Foundation Trust (THH) stakeholder event – Healthwatch Hillingdon had been invited to attend.  The information discussed at the meeting was very high level and had lacked detail.  THH had made assurances this week that it would be forwarding a copy of its QA report to HCCG by the end of the following week so that comments could be reflected in the final version.

Ms Roye noted that HCCG held regular quality meetings with THH to review what had been achieved and look at what was expected into the future.  Clinical Quality Review Group (CQRG) meetings were held with reports being considered by the Quality, Safety and Clinical Risk Committee (QSCRC) and the Trust Board.

Members were advised that HCCG had been meeting with THH on a monthly basis and working on the CQC action plan.  HCCG had met with regulators during the previous week to discuss the THH CQC action plan and provide assurances that action was being taken.  It was anticipated that the new THH leadership team would provide a different response to the improvements required by the CQC action plan.  Although it would take time for the improvements to take effect, developments were starting to  ...  view the full minutes text for item 54.